Implications of CLSPN Variants in Cellular Function and Susceptibility to Cancer. (2020)
Attributed to:
Targeting the FOXM1 signature for early diagnosis and treatment in cholangiocarcinoma
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.3390/cancers12092396
PubMed Identifier: 32847043
Publication URI: http://europepmc.org/abstract/MED/32847043
Type: Journal Article/Review
Volume: 12
Parent Publication: Cancers
Issue: 9
ISSN: 2072-6694